Restart Life Sciences Corp. (CSE:HEAL)

Canada flag Canada · Delayed Price · Currency is CAD
0.1000
-0.0050 (-4.76%)
At close: Mar 20, 2026
Market Cap5.93M +299.5%
Revenue (ttm)n/a
Net Income-1.23M
EPS-0.05
Shares Out59.25M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume189,500
Average Volume74,880
Open0.0950
Previous Close0.1050
Day's Range0.0900 - 0.1000
52-Week Range0.0450 - 0.1350
Beta-0.99
RSI46.50
Earnings DateApr 8, 2026

About Restart Life Sciences

Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company worldwide. It engages in developing natural remedies specifically tailored for individuals on the autism spectrum; health-related foods that promote both mind and body wellness for healthy living, as well as psilocybin clinical trial for fragile X syndrome. The company has collaboration with the University of Manitoba’s Richardson Centre for food technology and research (RCFTR) to support a series of food-related scientific studies. The company was former... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2004
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol HEAL
Full Company Profile

Financial Performance

Financial Statements